valerylsalicylate has been researched along with ng-nitroarginine methyl ester in 1 studies
Studies (valerylsalicylate) | Trials (valerylsalicylate) | Recent Studies (post-2010) (valerylsalicylate) | Studies (ng-nitroarginine methyl ester) | Trials (ng-nitroarginine methyl ester) | Recent Studies (post-2010) (ng-nitroarginine methyl ester) |
---|---|---|---|---|---|
24 | 0 | 5 | 12,640 | 117 | 2,342 |
Protein | Taxonomy | valerylsalicylate (IC50) | ng-nitroarginine methyl ester (IC50) |
---|---|---|---|
Neutrophil elastase | Homo sapiens (human) | 2.7 | |
Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.1 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 1.1167 | |
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.6 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 8 | |
Collagenase 3 | Homo sapiens (human) | 2.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, A; Jacobson, A; Kaley, G; Liu, H; Ojaimi, C; Sun, D; Yan, C | 1 |
1 other study(ies) available for valerylsalicylate and ng-nitroarginine methyl ester
Article | Year |
---|---|
COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice.
Topics: Animals; Arterioles; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Membrane Proteins; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitrobenzenes; Prostaglandins; Regional Blood Flow; Salicylates; Sulfonamides; Vasodilation | 2006 |